BIOMARIN PHARMACEUTICAL INC Maturities of Subordinated Debt
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Maturities of Subordinated Debt of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:MaturitiesOfSubordinatedDebt · last filed 2014-05-02
- BIOMARIN PHARMACEUTICAL INC maturities of subordinated debt for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC maturities of subordinated debt for the quarter ending 2013-12-31 was $0.00.
- BIOMARIN PHARMACEUTICAL INC maturities of subordinated debt for the quarter ending 2013-09-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC maturities of subordinated debt for the quarter ending 2013-06-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC maturities of subordinated debt for fiscal 2013 was $98.00K.
- BIOMARIN PHARMACEUTICAL INC maturities of subordinated debt for fiscal 2012 was $0.00.
- BIOMARIN PHARMACEUTICAL INC maturities of subordinated debt for fiscal 2011 was $0.00.
| Period end | Maturities of Subordinated Debt 3 month | Maturities of Subordinated Debt 6 month | Maturities of Subordinated Debt 9 month | Maturities of Subordinated Debt 12 month |
|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-02 | $0.00 derived: sum of 2 quarters · filed 2014-05-02 | $0.00 derived: sum of 3 quarters · filed 2014-05-02 | $0.00 derived: sum of 4 quarters · filed 2014-05-02 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $0.00 derived: sum of 2 quarters · filed 2014-02-26 | $0.00 derived: sum of 3 quarters · filed 2014-02-26 | $98.00K 10-K · filed 2014-02-26 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $0.00 derived: sum of 2 quarters · filed 2013-10-28 | $98.00K 10-Q · filed 2013-10-28 | $98.00K derived: sum of 4 quarters · filed 2014-05-02 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | $98.00K 10-Q · filed 2013-07-29 | $98.00K derived: sum of 3 quarters · filed 2014-05-02 | $98.00K derived: sum of 4 quarters · filed 2014-05-02 |
| 2013-03-31 | $98.00K 10-Q · filed 2014-05-02 | $98.00K derived: sum of 2 quarters · filed 2014-05-02 | $98.00K derived: sum of 3 quarters · filed 2014-05-02 | $98.00K derived: sum of 4 quarters · filed 2014-05-02 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $0.00 derived: sum of 2 quarters · filed 2014-02-26 | $0.00 derived: sum of 3 quarters · filed 2014-02-26 | $0.00 10-K · filed 2014-02-26 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $0.00 derived: sum of 2 quarters · filed 2013-10-28 | $0.00 10-Q · filed 2013-10-28 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | $0.00 10-Q · filed 2013-07-29 | ||
| 2012-03-31 | $0.00 10-Q · filed 2013-04-29 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |